Kyle Robert A, Therneau Terry M, Rajkumar S Vincent, Larson Dirk R, Plevak Matthew F, Offord Janice R, Dispenzieri Angela, Katzmann Jerry A, Melton L Joseph
Division of Hematology, Mayo Clinic, Rochester, Minn 55905, USA.
N Engl J Med. 2006 Mar 30;354(13):1362-9. doi: 10.1056/NEJMoa054494.
The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has not been accurately determined. We used sensitive laboratory techniques to ascertain the prevalence of MGUS in a large population in a well-defined geographic area.
We identified all living residents of Olmsted County, Minnesota, as of January 1, 1995. We obtained serum that remained after the performance of routine clinical tests at Mayo Clinic or asked subjects for whom such serum was unavailable to provide a sample. Agarose-gel electrophoresis was performed on all serum samples, and any serum sample with a discrete band of monoclonal protein or thought to have a localized band was subjected to immunofixation.
Serum samples were obtained from 21,463 of the 28,038 enumerated residents 50 years of age or older (76.6 percent). MGUS was identified in 694 (3.2 percent) of these persons. Age-adjusted rates were higher in men than in women (4.0 percent vs. 2.7 percent, P<0.001). The prevalence of MGUS was 5.3 percent among persons 70 years of age or older and 7.5 percent among those 85 years of age or older. The concentration of monoclonal immunoglobulin was less than 1.0 g per deciliter in 63.5 percent and at least 2.0 g per deciliter in only 4.5 percent of 694 persons. The concentration of uninvolved immunoglobulins was reduced in 27.7 percent of 447 persons tested, and 21.5 percent of 79 tested had a monoclonal urinary light chain.
Among residents of Olmsted County, Minnesota, MGUS was found in 3.2 percent of persons 50 years of age or older and 5.3 percent of persons 70 years of age or older.
意义未明的单克隆丙种球蛋白病(MGUS)是一种癌前浆细胞疾病,50岁及以上人群中的患病率尚未得到准确测定。我们使用敏感的实验室技术来确定明确定义的地理区域内一大群人中MGUS的患病率。
我们确定了截至1995年1月1日明尼苏达州奥尔姆斯特德县的所有在世居民。我们获取了梅奥诊所常规临床检测后剩余的血清,或者要求没有此类血清的受试者提供样本。对所有血清样本进行琼脂糖凝胶电泳,任何具有离散单克隆蛋白条带或被认为有局限性条带的血清样本都进行免疫固定。
在28,038名登记的50岁及以上居民中,有21,463人(76.6%)提供了血清样本。在这些人中,有694人(3.2%)被诊断为MGUS。年龄调整后的患病率男性高于女性(4.0%对2.7%,P<0.001)。70岁及以上人群中MGUS的患病率为5.3%,85岁及以上人群中为7.5%。在694名患者中,63.5%的患者单克隆免疫球蛋白浓度低于每分升1.0克;只有4.5%的患者单克隆免疫球蛋白浓度至少为每分升2.0克。在447名接受检测的患者中,27.7%的患者未受累免疫球蛋白浓度降低,在79名接受检测的患者中,21.5%的患者有单克隆尿轻链。
在明尼苏达州奥尔姆斯特德县的居民中,50岁及以上人群中MGUS的患病率为3.2%,70岁及以上人群中为5.3%。